P2-254: Pulmonary toxicity in patients treated with a combination of gemcitabine (G) associated to docetaxel (D) or vinorelbine (V) for advanced non-small cell lung cancer (NSCLC): outcome data on a randomized phase II study

Authors :: Noemi Villanueva
M. Luque
M. Capelan
Paula Jimenez
Joaquin Fra
Angel J. Lacave
B. Llorente
Yolanda Fernández
Emilio Esteban
I. Muñiz
Source :: Journal of Thoracic Oncology. 2(8):S673-S674
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Oncology
Pulmonary and Respiratory Medicine
medicine.medical_specialty
business.industry
Pulmonary toxicity
Phases of clinical research
non-small cell lung cancer (NSCLC)
Vinorelbine
medicine.disease
Gemcitabine
Docetaxel
Internal medicine
Medicine
In patient
Outcome data
business
medicine.drug

Full Text Access

Tools